Novartis | Deudores Comerciales



Trade Debtors Cambio Fecha
AbbVie USD 10.92B 553M 2024-12
Alcon AG USD 1.86B 225M 2025-03
Almirall EUR 173.08M 5.07M 2024-12
Amgen USD 8.13B 1.35B 2025-03
AstraZeneca USD 14.82B 16M 2025-03
Autolus Therapeutics Ltd 65.34M 17.1M 2025-03
Bayer EUR 16.74B 4.24B 2025-03
Biogen USD 2B 127.7M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Eli Lilly USD 14B 727.8M 2025-03
Fresenius EUR 3.94B 437M 2025-03
Fresenius Medical Care EUR 3.57B 198M 2025-03
Galapagos EUR 83.49M 3.87M 2025-03
Genmab DKK 799M 5.89B 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
GRIFOLS EUR 1.04B 167.7M 2025-03
Hikma Pharmaceutical USD 973M 8M 2024-12
J&J USD 16.02B 1.18B 2025-03
Lonza CHF 1.33B 269M 2024-12
Merck EUR 4.98B 387M 2025-03
Merck USD 11.57B 452M 2025-03
Novartis USD 9B 854M 2024-12
Novartis USD 7.56B 594M 2024-12
Novo Nordisk 86.37B 6.74B 2025-03
Orion EUR 391.3M 900K 2025-03
Pfizer USD 14.74B 32M 2025-03
Philips EUR 3.48B 289M 2025-03
Recordati EUR 706.33M 129.35M 2025-03
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
UCB EUR 1.58B 157M 2024-12



Novartis Deudores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.